Hester Bios

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE782E01017
NSEID: HESTERBIO
BSEID: 524669
View on NSE | View on BSE

INR

2,531.25

421.85 (20.0%)

BSENSE

Jul 13, 01:45 PM

BSE+NSE Vol: 4.25 lacs

{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,531.25",
    "chg": 421.85,
    "chgp": "20.0%",
    "dir": 1,
    "prev_price": "2,109.40",
    "mcapval": "1,979.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE782E01017",
    "curr_date": "Jul 13, 01:45 PM",
    "curr_time": "13:53 PM",
    "last_traded_at": "Jul 13, 01:45 PM IST",
    "bse_nse_vol": "4.25 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 13, 2026",
    "traded_date_str": "2026 07 13",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hester-bios-324228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-surges-20-to-hit-upper-circuit-amid-strong-buying-pressure-4098503",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HesterBioscienc_stocks_hitting_upper_circuit_4098503.png",
        "date": "2026-07-13 11:00:11",
        "description": "At Rs 2,545, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Hester Biosciences Ltd locked at its upper circuit of 20% on 13 Jul 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Hester Biosciences Ltd to 52-Week High of Rs 2399.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-hits-new-52-week-high-at-rs23993-4098238",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HesterBioscienc_priceRelatedfactors_4098238.png",
        "date": "2026-07-13 10:12:09",
        "description": "With a decisive surge to Rs 2399.3 on 13 Jul 2026, Hester Biosciences Ltd has marked a new 52-week high, extending its impressive 33.9% gain over the past year. This rally stands out amid a broadly subdued market backdrop, underscoring the stock’s strong technical momentum and sustained buying interest."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-hold-4097214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HesterBioscienc_mojoScore_4097214.png",
        "date": "2026-07-12 10:10:37",
        "description": "Hester Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-hold-4081365",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HesterBioscienc_mojoScore_4081365.png",
        "date": "2026-07-01 10:11:08",
        "description": "Hester Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 01 July 2026, providing investors with the latest comprehensive analysis."
      },
      {
        "title": "Hester Biosciences Ltd Quality Grade Downgrade Highlights Mixed Business Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-quality-grade-downgrade-highlights-mixed-business-fundamentals-4077632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_qualitydot_4077632.png",
        "date": "2026-06-30 08:00:05",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently seen its quality grade downgraded from average to below average by MarketsMOJO as of 8 June 2026. This shift reflects a nuanced change in the company’s underlying business fundamentals, including key metrics such as return on equity (ROE), return on capital employed (ROCE), debt levels, and growth consistency. This article delves into these parameters to assess what has improved and what has deteriorated, providing investors with a comprehensive understanding of the company’s current standing."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-hold-by-marketsmojo-4065200",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_mojoScore_4065200.png",
        "date": "2026-06-20 10:10:03",
        "description": "Hester Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4058055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_technicaldot_4058055.png",
        "date": "2026-06-17 08:01:35",
        "description": "Hester Biosciences Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish to a bullish stance across key indicators. Despite a slight dip in the daily price, the stock’s weekly and monthly technical parameters suggest strengthening momentum, positioning it favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Hester Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-sees-technical-momentum-shift-amid-strong-price-gains-4054905",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_technicaldot_4054905.png",
        "date": "2026-06-16 08:01:49",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, reflected in a 5.57% surge in its share price to ₹2,069.50 on 16 Jun 2026. This price movement accompanies a technical rating upgrade from Sell to Hold, signalling a cautiously optimistic outlook amid mixed indicator signals across weekly and monthly timeframes."
      },
      {
        "title": "Hester Biosciences Declines 1.83%: Mixed Signals and Technical Shifts Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-declines-183-mixed-signals-and-technical-shifts-shape-the-week-4053023",
        "imagepath": "",
        "date": "2026-06-14 13:00:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> MarketsMOJO downgraded Hester Biosciences Ltd to Sell amid mixed financial and technical signals</p>\n                    <p><strong>2 June:</strong> Technical momentum shifted from mildly bullish to sideways trend</p>\n                    <p><strong>3 June:</strong> Technical momentum shifted again, this time to mildly bullish</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.1,964.35, down 1.83% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,000.95</div></div>\n                    <div class=\"stat-item\"..."
      }
    ],
    "total": 5486,
    "sid": "324228",
    "stock_news_url": "https://www.marketsmojo.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI Listing Regulations- Sale Of Equity Investment In Texas Lifesciences Private Limited",
      "datetime": "09-Jul-2026",
      "details": "Disclosure under Regulation 30 of the SEBI Listing Regulations - Sale of Equity Investment in Texas Lifesciences Private Limited",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Jul-2026",
      "details": "Newspaper publication dated 9 July 2026 for the Transfer of Equity Shares of the Company to IEPF on compliance of IEPF Rules",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Jul-2026",
      "details": "Newspaper clipping for the publication dated 9 July 2026 for Corrigendum to the Notice convening 39th Annual General Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>110%</strong> dividend, ex-date: 14 Jul 26",
          "dt": "2026-07-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Hester Biosciences Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent

2026-07-13 11:00:11

At Rs 2,545, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Hester Biosciences Ltd locked at its upper circuit of 20% on 13 Jul 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Broad-Based Technical Strength Lifts Hester Biosciences Ltd to 52-Week High of Rs 2399.3

2026-07-13 10:12:09

With a decisive surge to Rs 2399.3 on 13 Jul 2026, Hester Biosciences Ltd has marked a new 52-week high, extending its impressive 33.9% gain over the past year. This rally stands out amid a broadly subdued market backdrop, underscoring the stock’s strong technical momentum and sustained buying interest.

Read full news article

Hester Biosciences Ltd is Rated Hold

2026-07-12 10:10:37

Hester Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Hester Biosciences Ltd is Rated Hold

2026-07-01 10:11:08

Hester Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 01 July 2026, providing investors with the latest comprehensive analysis.

Read full news article

Hester Biosciences Ltd Quality Grade Downgrade Highlights Mixed Business Fundamentals

2026-06-30 08:00:05

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently seen its quality grade downgraded from average to below average by MarketsMOJO as of 8 June 2026. This shift reflects a nuanced change in the company’s underlying business fundamentals, including key metrics such as return on equity (ROE), return on capital employed (ROCE), debt levels, and growth consistency. This article delves into these parameters to assess what has improved and what has deteriorated, providing investors with a comprehensive understanding of the company’s current standing.

Read full news article

Hester Biosciences Ltd is Rated Hold by MarketsMOJO

2026-06-20 10:10:03

Hester Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-17 08:01:35

Hester Biosciences Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish to a bullish stance across key indicators. Despite a slight dip in the daily price, the stock’s weekly and monthly technical parameters suggest strengthening momentum, positioning it favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Hester Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Gains

2026-06-16 08:01:49

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, reflected in a 5.57% surge in its share price to ₹2,069.50 on 16 Jun 2026. This price movement accompanies a technical rating upgrade from Sell to Hold, signalling a cautiously optimistic outlook amid mixed indicator signals across weekly and monthly timeframes.